Investors in Health

UvA - AMC - HvA Ventures | Holding BV is an asset management division owned by the University of Amsterdam, Academic Medical Center and the University of Applied Sciences of Amsterdam. New ventures, a subdivision within the holding, focuses on supporting high tech spinouts from the University of Amsterdam and the Academic Medical Center. We invest at pre-seed and seed stages in companies with novel technological innovations, high growth potential and social impact.

Monograph Capital is a venture firm focused on life sciences. With a dedicated emphasis on the life sciences sector, Monograph Capital invests in innovative companies and technologies that aim to advance healthcare and biotechnology. The firm supports early-stage ventures as well as growth-stage companies, providing critical capital, strategic guidance, and industry expertise to drive their development and success. Monograph Capital's investments span across biotech, pharmaceuticals, medical devices, and other areas within the life sciences field, aiming to contribute to breakthrough discoveries, therapies, and medical advancements. Through its strategic investments, Monograph Capital plays a crucial role in accelerating innovation and improving health outcomes globally.

BOM Brabant Ventures is the venture capital arm of Brabant Development Agency (BOM), focusing on investments in innovative companies across the Dutch province of North Brabant. As a regional development agency, BOM Brabant Ventures plays a vital role in supporting the growth and competitiveness of local businesses. The firm targets early-stage and growth-stage companies operating in sectors such as high-tech systems & materials, life sciences & health, agri-food, and sustainable energy. BOM Brabant Ventures provides financial investment, strategic guidance, and access to its extensive network of partners and industry experts to help startups scale their operations and enter new markets. By fostering innovation and entrepreneurship, BOM Brabant Ventures contributes to the economic development of North Brabant, creating job opportunities and stimulating technological advancements. The firm also collaborates closely with other regional and national stakeholders to strengthen the innovation ecosystem and attract talent and investment to the region.

Coalition Capital is an breakout venture capital firm, set up by a team of venture and growth equity veterans, with support from founders and executives from Prosus and Adyen, among others. Building on our track-record of backing unicorn and decacorn founders and our unique network, we seek to back the most daring and promising European founders at the Seed to Series B stage.

Tyson & Blake is committed to investing in inspiring founders who bring innovative approaches and technologies that deliver positive impact and long-term value. With a focus on supporting visionary entrepreneurs, Tyson & Blake identifies and nurtures ventures that have the potential to create meaningful change in their respective industries. By providing strategic capital and operational support, Tyson & Blake aims to empower these founders to realize their visions and achieve sustainable growth and success.

Regenerate Ventures is an early-stage investor focused on leading agricultural innovation companies. The firm identifies and supports startups that are pioneering advancements in agriculture, with a particular emphasis on sustainable practices, technologies, and solutions. Regenerate Ventures provides crucial capital, strategic guidance, and industry expertise to help these companies scale their operations and accelerate their impact on the agricultural sector. By investing in innovative agricultural technologies and practices, Regenerate Ventures aims to drive positive environmental outcomes, enhance food security, and promote sustainable farming practices globally. The firm plays a pivotal role in supporting the transition towards a more sustainable and resilient agricultural industry.

Curie Capital is a life science-focused venture capital firm dedicated to investing in groundbreaking healthcare innovations. They support early-stage companies developing transformative technologies and therapies. With a commitment to advancing medical science, Curie Capital provides strategic funding and guidance to foster growth and success in the life sciences sector.

Leela Capital embraces the concept of "Leela" from Sanskrit, symbolizing the playful creation of the cosmos. This philosophy underpins their values of collaboration, authenticity, acceptance, vulnerability, and being results-driven. Leela Capital focuses on providing capital to support innovative business models, aligning fully with their clients' success to celebrate achievements together. They emphasize humility, humanity, and resilience in their approach, fostering a supportive environment where strengths are valued and weaknesses are understood to build a cohesive and effective team.

Blume Equity is a growth equity firm specializing in climate-tech investments. The firm focuses on investing in companies that are dedicated to driving sustainable outcomes for the planet and people. Blume Equity provides growth capital and strategic support to help these companies scale their operations, expand their impact, and achieve sustainability goals. By backing climate-tech ventures, Blume Equity aims to accelerate the transition to a sustainable economy and promote innovations that mitigate environmental impacts. The firm plays a critical role in supporting and empowering companies that are pioneering solutions to global climate challenges.

Yarrow Capital specializes in backing early-stage entrepreneurs focused on building disruptive technologies and high-growth businesses. With a strong emphasis on innovation and strategic investment, Yarrow Capital supports visionary founders in realizing their potential and scaling transformative ideas. By providing capital, mentorship, and strategic guidance, Yarrow Capital plays a crucial role in nurturing innovation and driving forward the next generation of groundbreaking ventures.

AIV Capital is a private equity and venture capital investor that collaborates with dynamic companies and strong management teams. The firm focuses on identifying promising investment opportunities across various sectors and stages of growth. AIV Capital provides strategic capital, operational support, and industry expertise to help portfolio companies achieve their growth objectives. By partnering closely with management teams, AIV Capital aims to drive value creation, foster innovation, and accelerate business expansion. The firm plays a pivotal role in supporting entrepreneurial ventures and contributing to their success in competitive markets.

Disruptive Technology Ventures is a privately held investment firm in disruptive technologies. We believe groundbreaking technologies can help resolve the big challenges the world is facing and can improve our lives. Our mission is to bring the most promising, unique and groundbreaking new technologies to the market in their optimal business model in order to deliver the impact these technologies deserve.